No Data
No Data
Express News | Benchmark Reiterates Buy on PetIQ, Maintains $30 Price Target
PetIQ Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/10/2024 60.69% Benchmark → $30 Reiterates Buy → Buy 03/19/2024 49.97% Jefferies $24 → $28 Maintains Buy
Analysts Have Conflicting Sentiments on These Healthcare Companies: Petiq (PETQ), Leafly Holdings, Inc. (LFLY) and AMN Healthcare Services (AMN)
PetIQ | 10-Q: Quarterly report
Analysts Offer Insights on Healthcare Companies: GoodRx Holdings (GDRX), Petiq (PETQ) and Biodesix (BDSX)
Oppenheimer Sticks to Their Hold Rating for Petiq (PETQ)